Clinical Trials on Propofol Plasma Concentration in Korea, Republic of
Total 310 results
-
National Cancer Institute (NCI)CompletedDS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
MedImmune LLCCompletedAcute Myeloid Leukemia | Multiple Myeloma | Diffuse Large B-cell LymphomaUnited States, France, Korea, Republic of
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol SpecificUnited States, Canada
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol SpecificUnited States, Australia
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
TakedaTakeda Development Center Americas, Inc.Active, not recruitingLymphoma | Multiple Myeloma | AmyloidosisUnited States, China, Belgium, Canada, Poland, Spain, Korea, Republic of, Greece, Singapore, Japan, Sweden
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLymphoma | Leukemia | Breast Cancer | Chronic Myeloproliferative Disorders | Anemia | Small Intestine Cancer | Lung Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous Condition | Drug/Agent Toxicity by Tissue/OrganUnited States, Canada
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol SpecificUnited States, Canada
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
GlaxoSmithKlineRecruitingMultiple MyelomaAustralia, Germany, Italy, Spain, United States, Korea, Republic of, Canada, France, Poland, United Kingdom
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol SpecificUnited States, Canada, Australia
-
Genentech, Inc.Hoffmann-La RocheRecruitingMultiple MyelomaKorea, Republic of, United States, Denmark, Italy, Spain, France, Japan, Israel, United Kingdom, Poland, Australia, Czechia, Canada
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Neutropenia | InfectionUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol SpecificUnited States, Canada, Australia
-
Janssen Research & Development, LLCRecruitingMultiple MyelomaUnited States, Korea, Republic of, Canada, Israel, Australia, Spain, Japan
-
Regeneron PharmaceuticalsRecruitingMultiple MyelomaJapan, Belgium, United States, Korea, Republic of, Germany, Spain, United Kingdom
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, Australia, France, Spain, Israel, India, Romania, Korea, Republic of, Singapore, Russian Federation, Poland
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol SpecificUnited States, Canada
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol SpecificUnited States, Australia, Canada, Switzerland
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol SpecificUnited States, Canada
-
Centocor, Inc.WithdrawnMultiple MyelomaCanada, United States, Belgium, Poland, Bulgaria, Turkey, Ukraine, Australia, Korea, Republic of, New Zealand, Czech Republic, United Kingdom, Netherlands, India
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation TrustRecruiting
-
Merz Aesthetics GmbHCompletedPlatysma ProminenceUnited States
-
University of South FloridaNational Cancer Institute (NCI)CompletedDepression | Unspecified Adult Solid Tumor, Protocol Specific | Anxiety DisorderUnited States
-
Austrian Forum Against CancerCompletedMultiple MyelomaAustria, Czech Republic
-
SanofiActive, not recruitingPlasma Cell MyelomaFrance, United States, Australia, Brazil, Canada, Czechia, Greece, Hungary, Italy, Japan, Korea, Republic of, New Zealand, Russian Federation, Spain, Turkey, United Kingdom
-
Georgetown UniversityDaiichi Sankyo, Inc.Terminated
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
AGC Biologics S.p.A.Horizon 2020 - European CommissionTerminatedAcute Myeloid Leukemia | Multiple MyelomaItaly, Czechia
-
SanofiCompletedPlasma Cell MyelomaFrance, Spain, Greece, Korea, Republic of, United States, Australia, Belgium, Canada, Czechia, Denmark, Germany, Hungary, Italy, Japan, New Zealand, Norway, Poland, Portugal, Russian Federation, Slovakia, Sweden, Taiwan, Turkey, United...
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI); European Organisation for Research and Treatment... and other collaboratorsCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States, Canada
-
GlaxoSmithKlineRecruitingMultiple MyelomaUnited States, Greece, Korea, Republic of, Singapore
-
Hackensack Meridian HealthTerminatedMultiple MyelomaUnited States
-
TakedaActive, not recruitingMultiple MyelomaSpain, United States, Australia, China, Korea, Republic of, Canada, France
-
Hackensack Meridian HealthSuspendedMultiple MyelomaUnited States
-
Hackensack Meridian HealthKaryopharm Therapeutics IncRecruitingMultiple MyelomaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedMultiple Myeloma | Plasma Cell NeoplasmUnited States
-
Alexion Pharmaceuticals, Inc.Active, not recruitingAL AmyloidosisUnited States, Germany, Spain, Russian Federation, France, Korea, Republic of, Poland, Israel, Netherlands, Japan, Belgium, Greece, Switzerland, Australia, Austria, Brazil, Canada, China, Czechia, Italy, United Kingdom
-
National Cancer Institute (NCI)CompletedDexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple MyelomaMultiple Myeloma and Plasma Cell NeoplasmUnited States, Puerto Rico, South Africa
-
TakedaRecruitingMultiple MyelomaRussian Federation
-
Janssen Research & Development, LLCRecruitingMultiple MyelomaKorea, Republic of, United States, Russian Federation, Spain, France, China, Germany, Belgium, Denmark, Greece, Ukraine, Poland
-
Austrian Forum Against CancerCompletedMultiple Myeloma | Renal InsuficiencyAustria, Czech Republic
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Leukemia | Anemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Alexion Pharmaceuticals, Inc.Active, not recruitingAL AmyloidosisUnited States, Germany, Spain, United Kingdom, France, Korea, Republic of, Poland, Netherlands, Japan, Belgium, Greece, Australia, Austria, Brazil, Canada, China, Czechia, Israel, Italy, Russian Federation
-
AEterna ZentarisDana-Farber Cancer InstituteTerminatedMultiple MyelomaIsrael, Spain, Korea, Republic of, United States, Russian Federation, Canada, Ireland, Czechia, Slovakia
-
BayerCompletedBreast Neoplasms | Prostatic Neoplasms | Multiple Myeloma | OsteolysisCzech Republic
-
Janssen Research & Development, LLCCompletedHigh-risk Smoldering Multiple MyelomaUnited States, United Kingdom, Belgium, Germany, France, Spain, Korea, Republic of, Australia, Israel, Greece, Sweden
-
Spine Centre of Southern DenmarkRecruitingMultiple Myeloma | Vertebral FractureDenmark